GelPOINT® Path-Assisted Endoscopic Removal of Colon and Rectal Polyps: A Feasibility and Safety Study

Part of paid clinical trials in Houston, Texas.

Sponsor
Baylor College of Medicine
Study ID
NCT07723937
Status
Recruiting

Conditions

  • Adenoma Colon Polyp
  • Polyp Colorectal
  • Rectal Adenoma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This prospective, single-center, observational feasibility and safety study will evaluate the use of the GelPOINT® Path transanal access platform during endoscopic submucosal dissection (ESD) for the removal of colorectal polyps. The GelPOINT® Path system is designed to improve access, maintain stable insufflation, and enhance visualization during advanced endoscopic procedures. The study will enroll adult patients undergoing ESD for eligible colorectal lesions. The primary objective is to evaluate the technical feasibility, procedural performance, and safety of GelPOINT® Path-assisted ESD. Procedural outcomes, including procedure speed, technical success, resection outcomes, and procedure-related adverse events, will be collected prospectively. Participants will receive standard clinical care and will be followed for approximately 4 weeks after the procedure to assess delayed adverse events.

Key Dates

First listed
Jul 23, 2026
Start date
May 19, 2026
Status verified
Apr 2026
Primary completion
Mar 25, 2027
Completion
Apr 30, 2027

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: GelPOINT® Path-Assisted ESD
    Adult participants undergoing endoscopic submucosal dissection (ESD) for eligible colorectal polyps using the GelPOINT® Path transanal access platform as part of standard clinical care. The study will prospectively evaluate the feasibility, technical performance, and safety of GelPOINT® Path-assisted ESD, including procedural outcomes and procedure-related adverse events.

Primary Outcome Measure

Procedure Speed [ Time Frame: During the index procedure ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Baylor College of MedicineHoustonTexas77030
Tara A Keihanian, MD
631-800-4142
Haydee Rochits Cueto
713-798-3606
Mohamed Othman, MD (SUB_INVESTIGATOR)
Fares Ayoub, MD (SUB_INVESTIGATOR)

Find similar trials in Houston, TX

Related Studies